Cargando…
Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants
Little information is available regarding incidence and severity of pulmonary embolism (PE) across the periods of ancestral strain, Alpha, Delta, and Omicron variants. The aim of this study is to investigate the incidence and severity of PE over the dominant periods of ancestral strain and Alpha, De...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695578/ http://dx.doi.org/10.1097/MD.0000000000036417 |
_version_ | 1785153596486057984 |
---|---|
author | Wada, Noriaki Li, Yi Gagne, Staci Hino, Takuya Valtchinov, Vladimir I. Gay, Elizabeth Nishino, Mizuki Hammer, Mark M. Madore, Bruno Guttmann, Charles R. G. Ishigami, Kousei Hunninghake, Gary M. Levy, Bruce D. Kaye, Kenneth M. Christiani, David C. Hatabu, Hiroto |
author_facet | Wada, Noriaki Li, Yi Gagne, Staci Hino, Takuya Valtchinov, Vladimir I. Gay, Elizabeth Nishino, Mizuki Hammer, Mark M. Madore, Bruno Guttmann, Charles R. G. Ishigami, Kousei Hunninghake, Gary M. Levy, Bruce D. Kaye, Kenneth M. Christiani, David C. Hatabu, Hiroto |
author_sort | Wada, Noriaki |
collection | PubMed |
description | Little information is available regarding incidence and severity of pulmonary embolism (PE) across the periods of ancestral strain, Alpha, Delta, and Omicron variants. The aim of this study is to investigate the incidence and severity of PE over the dominant periods of ancestral strain and Alpha, Delta, and Omicron variants. We hypothesized that the incidence and the severity by proximity of PE in patients with the newer variants and vaccination would be decreased compared with those in ancestral and earlier variants. Patients with COVID-19 diagnosis between March 2020 and February 2022 and computed tomography pulmonary angiogram performed within a 6-week window around the diagnosis (−2 to +4 weeks) were studied retrospectively. The primary endpoints were the associations of the incidence and location of PE with the ancestral strain and each variant. Of the 720 coronavirus disease 2019 patients with computed tomography pulmonary angiogram (58.6 ± 17.2 years; 374 females), PE was diagnosed among 42/358 (12%) during the ancestral strain period, 5/60 (8%) during the Alpha variant period, 16/152 (11%) during the Delta variant period, and 13/150 (9%) during the Omicron variant period. The most proximal PE (ancestral strain vs variants) was located in the main/lobar arteries (31% vs 6%–40%), in the segmental arteries (52% vs 60%–75%), and in the subsegmental arteries (17% vs 0%–19%). There was no significant difference in both the incidence and location of PE across the periods, confirmed by multivariable logistic regression models. In summary, the incidence and severity of PE did not significantly differ across the periods of ancestral strain and Alpha, Delta, and Omicron variants. |
format | Online Article Text |
id | pubmed-10695578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106955782023-12-05 Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants Wada, Noriaki Li, Yi Gagne, Staci Hino, Takuya Valtchinov, Vladimir I. Gay, Elizabeth Nishino, Mizuki Hammer, Mark M. Madore, Bruno Guttmann, Charles R. G. Ishigami, Kousei Hunninghake, Gary M. Levy, Bruce D. Kaye, Kenneth M. Christiani, David C. Hatabu, Hiroto Medicine (Baltimore) 6800 Little information is available regarding incidence and severity of pulmonary embolism (PE) across the periods of ancestral strain, Alpha, Delta, and Omicron variants. The aim of this study is to investigate the incidence and severity of PE over the dominant periods of ancestral strain and Alpha, Delta, and Omicron variants. We hypothesized that the incidence and the severity by proximity of PE in patients with the newer variants and vaccination would be decreased compared with those in ancestral and earlier variants. Patients with COVID-19 diagnosis between March 2020 and February 2022 and computed tomography pulmonary angiogram performed within a 6-week window around the diagnosis (−2 to +4 weeks) were studied retrospectively. The primary endpoints were the associations of the incidence and location of PE with the ancestral strain and each variant. Of the 720 coronavirus disease 2019 patients with computed tomography pulmonary angiogram (58.6 ± 17.2 years; 374 females), PE was diagnosed among 42/358 (12%) during the ancestral strain period, 5/60 (8%) during the Alpha variant period, 16/152 (11%) during the Delta variant period, and 13/150 (9%) during the Omicron variant period. The most proximal PE (ancestral strain vs variants) was located in the main/lobar arteries (31% vs 6%–40%), in the segmental arteries (52% vs 60%–75%), and in the subsegmental arteries (17% vs 0%–19%). There was no significant difference in both the incidence and location of PE across the periods, confirmed by multivariable logistic regression models. In summary, the incidence and severity of PE did not significantly differ across the periods of ancestral strain and Alpha, Delta, and Omicron variants. Lippincott Williams & Wilkins 2023-12-01 /pmc/articles/PMC10695578/ http://dx.doi.org/10.1097/MD.0000000000036417 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | 6800 Wada, Noriaki Li, Yi Gagne, Staci Hino, Takuya Valtchinov, Vladimir I. Gay, Elizabeth Nishino, Mizuki Hammer, Mark M. Madore, Bruno Guttmann, Charles R. G. Ishigami, Kousei Hunninghake, Gary M. Levy, Bruce D. Kaye, Kenneth M. Christiani, David C. Hatabu, Hiroto Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants |
title | Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants |
title_full | Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants |
title_fullStr | Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants |
title_full_unstemmed | Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants |
title_short | Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants |
title_sort | incidence and severity of pulmonary embolism in covid-19 infection: ancestral, alpha, delta, and omicron variants |
topic | 6800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695578/ http://dx.doi.org/10.1097/MD.0000000000036417 |
work_keys_str_mv | AT wadanoriaki incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT liyi incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT gagnestaci incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT hinotakuya incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT valtchinovvladimiri incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT gayelizabeth incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT nishinomizuki incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT hammermarkm incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT madorebruno incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT guttmanncharlesrg incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT ishigamikousei incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT hunninghakegarym incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT levybruced incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT kayekennethm incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT christianidavidc incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants AT hatabuhiroto incidenceandseverityofpulmonaryembolismincovid19infectionancestralalphadeltaandomicronvariants |